Division of Urologic Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Eur Urol. 2010 Feb;57(2):196-201. doi: 10.1016/j.eururo.2009.10.024. Epub 2009 Oct 20.
In recent years, surgeons have begun to report case series of minimally invasive approaches to radical cystectomy, including robotic-assisted techniques demonstrating the surgical feasibility of this procedure with the potential of lower blood loss and more rapid return of bowel function and hospital discharge. Despite these experiences and observations, at this point high levels of clinical evidence with regard to the benefits of robotic cystectomy are absent, and the current experiences represent case series with limited comparisons to historical controls at best.
We report our results on a prospective randomized trial of open versus robotic-assisted laparoscopic radical cystectomy with regard to perioperative outcomes, complications, and short-term narcotic usage.
DESIGN, SETTING, AND PARTICIPANTS: A prospective randomized single-center noninferiority study comparing open versus robotic approaches to cystectomy in patients who are candidates for radical cystectomy for urothelial carcinoma of the bladder. Of the 41 patients who underwent surgery, 21 were randomized to the robotic approach and 20 to the open technique.
Radical cystectomy, bilateral pelvic lymphadenectomy, and urinary diversion by either an open approach or by a robotic-assisted laparoscopic technique.
The primary end point was lymph node (LN) yield with a noninferiority margin of four LNs. Secondary end points included demographic characteristics, perioperative outcomes, pathologic results, and short-term narcotic use.
On univariate analysis, no significant differences were found between the two groups with regard to age, sex, body mass index, American Society of Anesthesiologists classification, anticoagulation regimen of aspirin, clinical stage, or diversion type. Significant differences were noted in operating room time, estimated blood loss, time to flatus, time to bowel movement, and use of inpatient morphine sulfate equivalents. There was no significant difference in regard to overall complication rate or hospital stay. On surgical pathology, in the robotic group 14 patients had pT2 disease or higher; 3 patients had pT3/T4 disease; and 4 patients had node-positive disease. In the open group, eight patients had pT2 disease or higher; five patients had pT3/T4 disease; and seven patients had node-positive disease. The mean number of LNs removed was 19 in the robotic group versus18 in the open group. Potential study limitations include the limited clinical and oncologic follow-up and the relatively small and single-institution nature of the study.
We present the results of a prospective randomized controlled noninferiority study with a primary end point of LN yield, demonstrating the robotic approach to be noninferior to the open approach. The robotic approach also compares favorably with the open approach in several perioperative parameters.
近年来,外科医生开始报告微创根治性膀胱切除术的病例系列,包括机器人辅助技术,这些技术证明了该手术的可行性,具有更低的出血量和更快的肠道功能恢复和出院的潜力。尽管有这些经验和观察,但目前关于机器人膀胱切除术的益处的临床证据水平仍然很高,目前的经验仅代表了与历史对照的最佳病例系列。
我们报告了一项前瞻性随机试验的结果,该试验比较了开放与机器人辅助腹腔镜根治性膀胱切除术在围手术期结果、并发症和短期阿片类药物使用方面的情况。
设计、地点和参与者:一项前瞻性随机单中心非劣效性研究,比较了机器人辅助与开放方法在适合根治性膀胱切除术的患者中的应用,这些患者患有膀胱癌的尿路上皮癌。在接受手术的 41 名患者中,21 名随机分配到机器人组,20 名随机分配到开放组。
根治性膀胱切除术、双侧盆腔淋巴结清扫术和尿流改道,采用开放或机器人辅助腹腔镜技术。
主要终点是淋巴结(LN)产量,非劣效性边界为 4 个 LN。次要终点包括人口统计学特征、围手术期结果、病理结果和短期阿片类药物使用。
在单变量分析中,两组在年龄、性别、体重指数、美国麻醉医师协会分类、阿司匹林抗凝方案、临床分期或分流类型方面无显著差异。在手术室时间、估计失血量、排气时间、排便时间和住院吗啡硫酸盐等效物使用方面存在显著差异。在总并发症发生率或住院时间方面无显著差异。在手术病理学方面,机器人组 14 例患者为 pT2 期或更高分期;3 例患者为 pT3/T4 期;4 例患者为淋巴结阳性疾病。在开放组中,8 例患者为 pT2 期或更高分期;5 例患者为 pT3/T4 期;7 例患者为淋巴结阳性疾病。机器人组平均切除淋巴结数为 19 个,开放组为 18 个。潜在的研究局限性包括有限的临床和肿瘤学随访以及研究的相对较小和单一机构性质。
我们提出了一项前瞻性随机对照非劣效性研究的结果,主要终点为淋巴结产量,证明机器人方法不劣于开放方法。机器人方法在几个围手术期参数方面也优于开放方法。